The Association of Third-Generation Cephalosporin Use and Invasive Candidiasis in Extremely Low Birth-Weight Infants
Previous studies have shown that incidence of invasive candidiasis varies substantially among centers, and previous use of broad-spectrum antibiotics is a risk factor for candidiasis in extremely low birth-weight infants. Differences in center practices, such as antibiotic strategies and the effects...
Gespeichert in:
| Veröffentlicht in: | Pediatrics (Evanston) 2006-08, Vol.118 (2), p.717-722 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 722 |
|---|---|
| container_issue | 2 |
| container_start_page | 717 |
| container_title | Pediatrics (Evanston) |
| container_volume | 118 |
| creator | Cotten, C. Michael McDonald, Scott Stoll, Barbara Goldberg, Ronald N Poole, Kenneth Benjamin, Daniel K., Jr on behalf of National Institute for Child Health and Human Development Neonatal Research Network |
| description | Previous studies have shown that incidence of invasive candidiasis varies substantially among centers, and previous use of broad-spectrum antibiotics is a risk factor for candidiasis in extremely low birth-weight infants. Differences in center practices, such as antibiotic strategies and the effects of these strategies on center incidence of candidiasis, are not reflected in assessments of an individual's risk of candidiasis. We evaluated the relationship between empirical antibiotic practices for extremely low birth-weight infants and center incidence of candidiasis.
We studied a cohort of extremely low birth-weight infants who survived > or = 72 hours and were admitted to 1 of 12 tertiary centers between 1998 and 2001. Multivariable logistic regression was used to validate previous broad-spectrum antibiotics use as a risk factor for subsequent candidiasis in individual infants. We calculated correlation coefficients to assess the relationship between center incidence of candidiasis with antibiotic practice patterns.
There were 3702 infants from 12 centers included, and 284 (7.7%) developed invasive candidiasis. Broad-spectrum antibiotics use was associated with candidiasis for individual infants. Center candidiasis incidence ranged from 2.4% to 20.4%. Center incidence of candidiasis was correlated with average broad-spectrum antibiotics use per infant and average use of broad-spectrum antibiotics with negative cultures per infant.
Center incidences of invasive candidiasis differ substantially, and antibiotic practice differences are possible contributors to center variation in candidiasis risk. |
| doi_str_mv | 10.1542/peds.2005-2677 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_68703643</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A156549594</galeid><sourcerecordid>A156549594</sourcerecordid><originalsourceid>FETCH-LOGICAL-c604t-d1d720a51b81160bf5e1b632412eb5d8fedada76dc5c8f99ec2be46fbc9b40613</originalsourceid><addsrcrecordid>eNptkk1rGzEQhpfS0rhprz2WpdBCD-tKWkmrPTomdQOGXBx6FFpp1quwllxJzse_r1wb3BSjgzQzz6sZhrcoPmI0xYyS71swcUoQYhXhTfOqmGDUioqShr0uJgjVuKK5eFG8i_EeIURZQ94WF5gLQfKZFGk1QDmL0WurkvWu9H25Gmww1QIchENuDttBjT5ufbCuvItQKmfKG_egon2Acp4ja2wOYpnr108pwAbG53LpH8srG9JQ_QK7HlKW9Mql-L5406sxwofjfVnc_bhezX9Wy9vFzXy2rDRHNFUGm4YgxXAnMOao6xngjteEYgIdM6IHo4xquNFMi75tQZMOKO873XYUcVxfFl8P_26D_72DmOTGRg3jqBz4XZRcNKjmtM7g5__Ae78LLs8mCRE15xQ3GaoO0FqNIK3rfQpKr_-uafQOepvTM8w4oy1raeanZ_h8DGysPiv49kKQmQRPaa12MUqxWL5kq3Os9uMIa5B5jfPbs8Po4GMM0MttsBsVniVGcu8kuXeS3DtJ7p2UBZ-OK9l1GzAn_GidDHw5AipqNfZBOW3jiRMItZg3p85DtsCjDbDvlM0WrI7_PDEWksgm7_kP7rrgTQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>228366417</pqid></control><display><type>article</type><title>The Association of Third-Generation Cephalosporin Use and Invasive Candidiasis in Extremely Low Birth-Weight Infants</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Cotten, C. Michael ; McDonald, Scott ; Stoll, Barbara ; Goldberg, Ronald N ; Poole, Kenneth ; Benjamin, Daniel K., Jr ; on behalf of National Institute for Child Health and Human Development Neonatal Research Network</creator><creatorcontrib>Cotten, C. Michael ; McDonald, Scott ; Stoll, Barbara ; Goldberg, Ronald N ; Poole, Kenneth ; Benjamin, Daniel K., Jr ; on behalf of National Institute for Child Health and Human Development Neonatal Research Network ; National Institute for Child Health and Human Development Neonatal Research Network ; on behalf of the National Institute for Child Health and Human Development Neonatal Research Network</creatorcontrib><description>Previous studies have shown that incidence of invasive candidiasis varies substantially among centers, and previous use of broad-spectrum antibiotics is a risk factor for candidiasis in extremely low birth-weight infants. Differences in center practices, such as antibiotic strategies and the effects of these strategies on center incidence of candidiasis, are not reflected in assessments of an individual's risk of candidiasis. We evaluated the relationship between empirical antibiotic practices for extremely low birth-weight infants and center incidence of candidiasis.
We studied a cohort of extremely low birth-weight infants who survived > or = 72 hours and were admitted to 1 of 12 tertiary centers between 1998 and 2001. Multivariable logistic regression was used to validate previous broad-spectrum antibiotics use as a risk factor for subsequent candidiasis in individual infants. We calculated correlation coefficients to assess the relationship between center incidence of candidiasis with antibiotic practice patterns.
There were 3702 infants from 12 centers included, and 284 (7.7%) developed invasive candidiasis. Broad-spectrum antibiotics use was associated with candidiasis for individual infants. Center candidiasis incidence ranged from 2.4% to 20.4%. Center incidence of candidiasis was correlated with average broad-spectrum antibiotics use per infant and average use of broad-spectrum antibiotics with negative cultures per infant.
Center incidences of invasive candidiasis differ substantially, and antibiotic practice differences are possible contributors to center variation in candidiasis risk.</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.2005-2677</identifier><identifier>PMID: 16882828</identifier><identifier>CODEN: PEDIAU</identifier><language>eng</language><publisher>Elk Grove Village, IL: Am Acad Pediatrics</publisher><subject>Antibiotics ; Bacterial diseases ; Bacterial sepsis ; Biological and medical sciences ; Birth weight ; Blood - microbiology ; Blood diseases ; Body fluids ; Candidiasis ; Candidiasis - epidemiology ; Candidiasis - etiology ; Carbapenems - therapeutic use ; Catheterization, Central Venous ; Central Nervous System Fungal Infections - epidemiology ; Central Nervous System Fungal Infections - etiology ; Central Nervous System Fungal Infections - microbiology ; Cephaloridine ; Cephalosporins ; Cephalosporins - classification ; Cephalosporins - therapeutic use ; Cerebrospinal Fluid - microbiology ; Comorbidity ; Complications and side effects ; Cross Infection - epidemiology ; Cross Infection - etiology ; Development and progression ; Diseases of mother, fetus and pregnancy ; Enterocolitis, Necrotizing - epidemiology ; Fungemia - epidemiology ; Fungemia - etiology ; Fungemia - microbiology ; General aspects ; Gram-Negative Bacterial Infections - drug therapy ; Gram-Negative Bacterial Infections - epidemiology ; Gynecology. Andrology. Obstetrics ; Health aspects ; Human bacterial diseases ; Humans ; Infant, Newborn ; Infant, Premature ; Infant, Premature, Diseases - epidemiology ; Infant, Premature, Diseases - etiology ; Infant, Very Low Birth Weight ; Infants (Premature) ; Infectious diseases ; Medical sciences ; Medical treatment ; Mortality ; Moxalactam ; Pediatrics ; Pregnancy. Fetus. Placenta ; Premature infants ; Prospective Studies ; Registries ; Risk Factors ; Studies ; Superinfection - epidemiology ; Superinfection - etiology</subject><ispartof>Pediatrics (Evanston), 2006-08, Vol.118 (2), p.717-722</ispartof><rights>2006 INIST-CNRS</rights><rights>COPYRIGHT 2006 American Academy of Pediatrics</rights><rights>Copyright American Academy of Pediatrics Aug 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c604t-d1d720a51b81160bf5e1b632412eb5d8fedada76dc5c8f99ec2be46fbc9b40613</citedby><cites>FETCH-LOGICAL-c604t-d1d720a51b81160bf5e1b632412eb5d8fedada76dc5c8f99ec2be46fbc9b40613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18009167$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16882828$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cotten, C. Michael</creatorcontrib><creatorcontrib>McDonald, Scott</creatorcontrib><creatorcontrib>Stoll, Barbara</creatorcontrib><creatorcontrib>Goldberg, Ronald N</creatorcontrib><creatorcontrib>Poole, Kenneth</creatorcontrib><creatorcontrib>Benjamin, Daniel K., Jr</creatorcontrib><creatorcontrib>on behalf of National Institute for Child Health and Human Development Neonatal Research Network</creatorcontrib><creatorcontrib>National Institute for Child Health and Human Development Neonatal Research Network</creatorcontrib><creatorcontrib>on behalf of the National Institute for Child Health and Human Development Neonatal Research Network</creatorcontrib><title>The Association of Third-Generation Cephalosporin Use and Invasive Candidiasis in Extremely Low Birth-Weight Infants</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><description>Previous studies have shown that incidence of invasive candidiasis varies substantially among centers, and previous use of broad-spectrum antibiotics is a risk factor for candidiasis in extremely low birth-weight infants. Differences in center practices, such as antibiotic strategies and the effects of these strategies on center incidence of candidiasis, are not reflected in assessments of an individual's risk of candidiasis. We evaluated the relationship between empirical antibiotic practices for extremely low birth-weight infants and center incidence of candidiasis.
We studied a cohort of extremely low birth-weight infants who survived > or = 72 hours and were admitted to 1 of 12 tertiary centers between 1998 and 2001. Multivariable logistic regression was used to validate previous broad-spectrum antibiotics use as a risk factor for subsequent candidiasis in individual infants. We calculated correlation coefficients to assess the relationship between center incidence of candidiasis with antibiotic practice patterns.
There were 3702 infants from 12 centers included, and 284 (7.7%) developed invasive candidiasis. Broad-spectrum antibiotics use was associated with candidiasis for individual infants. Center candidiasis incidence ranged from 2.4% to 20.4%. Center incidence of candidiasis was correlated with average broad-spectrum antibiotics use per infant and average use of broad-spectrum antibiotics with negative cultures per infant.
Center incidences of invasive candidiasis differ substantially, and antibiotic practice differences are possible contributors to center variation in candidiasis risk.</description><subject>Antibiotics</subject><subject>Bacterial diseases</subject><subject>Bacterial sepsis</subject><subject>Biological and medical sciences</subject><subject>Birth weight</subject><subject>Blood - microbiology</subject><subject>Blood diseases</subject><subject>Body fluids</subject><subject>Candidiasis</subject><subject>Candidiasis - epidemiology</subject><subject>Candidiasis - etiology</subject><subject>Carbapenems - therapeutic use</subject><subject>Catheterization, Central Venous</subject><subject>Central Nervous System Fungal Infections - epidemiology</subject><subject>Central Nervous System Fungal Infections - etiology</subject><subject>Central Nervous System Fungal Infections - microbiology</subject><subject>Cephaloridine</subject><subject>Cephalosporins</subject><subject>Cephalosporins - classification</subject><subject>Cephalosporins - therapeutic use</subject><subject>Cerebrospinal Fluid - microbiology</subject><subject>Comorbidity</subject><subject>Complications and side effects</subject><subject>Cross Infection - epidemiology</subject><subject>Cross Infection - etiology</subject><subject>Development and progression</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Enterocolitis, Necrotizing - epidemiology</subject><subject>Fungemia - epidemiology</subject><subject>Fungemia - etiology</subject><subject>Fungemia - microbiology</subject><subject>General aspects</subject><subject>Gram-Negative Bacterial Infections - drug therapy</subject><subject>Gram-Negative Bacterial Infections - epidemiology</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Health aspects</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Infant, Premature, Diseases - epidemiology</subject><subject>Infant, Premature, Diseases - etiology</subject><subject>Infant, Very Low Birth Weight</subject><subject>Infants (Premature)</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Medical treatment</subject><subject>Mortality</subject><subject>Moxalactam</subject><subject>Pediatrics</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Premature infants</subject><subject>Prospective Studies</subject><subject>Registries</subject><subject>Risk Factors</subject><subject>Studies</subject><subject>Superinfection - epidemiology</subject><subject>Superinfection - etiology</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkk1rGzEQhpfS0rhprz2WpdBCD-tKWkmrPTomdQOGXBx6FFpp1quwllxJzse_r1wb3BSjgzQzz6sZhrcoPmI0xYyS71swcUoQYhXhTfOqmGDUioqShr0uJgjVuKK5eFG8i_EeIURZQ94WF5gLQfKZFGk1QDmL0WurkvWu9H25Gmww1QIchENuDttBjT5ufbCuvItQKmfKG_egon2Acp4ja2wOYpnr108pwAbG53LpH8srG9JQ_QK7HlKW9Mql-L5406sxwofjfVnc_bhezX9Wy9vFzXy2rDRHNFUGm4YgxXAnMOao6xngjteEYgIdM6IHo4xquNFMi75tQZMOKO873XYUcVxfFl8P_26D_72DmOTGRg3jqBz4XZRcNKjmtM7g5__Ae78LLs8mCRE15xQ3GaoO0FqNIK3rfQpKr_-uafQOepvTM8w4oy1raeanZ_h8DGysPiv49kKQmQRPaa12MUqxWL5kq3Os9uMIa5B5jfPbs8Po4GMM0MttsBsVniVGcu8kuXeS3DtJ7p2UBZ-OK9l1GzAn_GidDHw5AipqNfZBOW3jiRMItZg3p85DtsCjDbDvlM0WrI7_PDEWksgm7_kP7rrgTQ</recordid><startdate>20060801</startdate><enddate>20060801</enddate><creator>Cotten, C. Michael</creator><creator>McDonald, Scott</creator><creator>Stoll, Barbara</creator><creator>Goldberg, Ronald N</creator><creator>Poole, Kenneth</creator><creator>Benjamin, Daniel K., Jr</creator><creator>on behalf of National Institute for Child Health and Human Development Neonatal Research Network</creator><general>Am Acad Pediatrics</general><general>American Academy of Pediatrics</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>20060801</creationdate><title>The Association of Third-Generation Cephalosporin Use and Invasive Candidiasis in Extremely Low Birth-Weight Infants</title><author>Cotten, C. Michael ; McDonald, Scott ; Stoll, Barbara ; Goldberg, Ronald N ; Poole, Kenneth ; Benjamin, Daniel K., Jr ; on behalf of National Institute for Child Health and Human Development Neonatal Research Network</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c604t-d1d720a51b81160bf5e1b632412eb5d8fedada76dc5c8f99ec2be46fbc9b40613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Antibiotics</topic><topic>Bacterial diseases</topic><topic>Bacterial sepsis</topic><topic>Biological and medical sciences</topic><topic>Birth weight</topic><topic>Blood - microbiology</topic><topic>Blood diseases</topic><topic>Body fluids</topic><topic>Candidiasis</topic><topic>Candidiasis - epidemiology</topic><topic>Candidiasis - etiology</topic><topic>Carbapenems - therapeutic use</topic><topic>Catheterization, Central Venous</topic><topic>Central Nervous System Fungal Infections - epidemiology</topic><topic>Central Nervous System Fungal Infections - etiology</topic><topic>Central Nervous System Fungal Infections - microbiology</topic><topic>Cephaloridine</topic><topic>Cephalosporins</topic><topic>Cephalosporins - classification</topic><topic>Cephalosporins - therapeutic use</topic><topic>Cerebrospinal Fluid - microbiology</topic><topic>Comorbidity</topic><topic>Complications and side effects</topic><topic>Cross Infection - epidemiology</topic><topic>Cross Infection - etiology</topic><topic>Development and progression</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Enterocolitis, Necrotizing - epidemiology</topic><topic>Fungemia - epidemiology</topic><topic>Fungemia - etiology</topic><topic>Fungemia - microbiology</topic><topic>General aspects</topic><topic>Gram-Negative Bacterial Infections - drug therapy</topic><topic>Gram-Negative Bacterial Infections - epidemiology</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Health aspects</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Infant, Premature, Diseases - epidemiology</topic><topic>Infant, Premature, Diseases - etiology</topic><topic>Infant, Very Low Birth Weight</topic><topic>Infants (Premature)</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Medical treatment</topic><topic>Mortality</topic><topic>Moxalactam</topic><topic>Pediatrics</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Premature infants</topic><topic>Prospective Studies</topic><topic>Registries</topic><topic>Risk Factors</topic><topic>Studies</topic><topic>Superinfection - epidemiology</topic><topic>Superinfection - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cotten, C. Michael</creatorcontrib><creatorcontrib>McDonald, Scott</creatorcontrib><creatorcontrib>Stoll, Barbara</creatorcontrib><creatorcontrib>Goldberg, Ronald N</creatorcontrib><creatorcontrib>Poole, Kenneth</creatorcontrib><creatorcontrib>Benjamin, Daniel K., Jr</creatorcontrib><creatorcontrib>on behalf of National Institute for Child Health and Human Development Neonatal Research Network</creatorcontrib><creatorcontrib>National Institute for Child Health and Human Development Neonatal Research Network</creatorcontrib><creatorcontrib>on behalf of the National Institute for Child Health and Human Development Neonatal Research Network</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cotten, C. Michael</au><au>McDonald, Scott</au><au>Stoll, Barbara</au><au>Goldberg, Ronald N</au><au>Poole, Kenneth</au><au>Benjamin, Daniel K., Jr</au><au>on behalf of National Institute for Child Health and Human Development Neonatal Research Network</au><aucorp>National Institute for Child Health and Human Development Neonatal Research Network</aucorp><aucorp>on behalf of the National Institute for Child Health and Human Development Neonatal Research Network</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Association of Third-Generation Cephalosporin Use and Invasive Candidiasis in Extremely Low Birth-Weight Infants</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>2006-08-01</date><risdate>2006</risdate><volume>118</volume><issue>2</issue><spage>717</spage><epage>722</epage><pages>717-722</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><coden>PEDIAU</coden><abstract>Previous studies have shown that incidence of invasive candidiasis varies substantially among centers, and previous use of broad-spectrum antibiotics is a risk factor for candidiasis in extremely low birth-weight infants. Differences in center practices, such as antibiotic strategies and the effects of these strategies on center incidence of candidiasis, are not reflected in assessments of an individual's risk of candidiasis. We evaluated the relationship between empirical antibiotic practices for extremely low birth-weight infants and center incidence of candidiasis.
We studied a cohort of extremely low birth-weight infants who survived > or = 72 hours and were admitted to 1 of 12 tertiary centers between 1998 and 2001. Multivariable logistic regression was used to validate previous broad-spectrum antibiotics use as a risk factor for subsequent candidiasis in individual infants. We calculated correlation coefficients to assess the relationship between center incidence of candidiasis with antibiotic practice patterns.
There were 3702 infants from 12 centers included, and 284 (7.7%) developed invasive candidiasis. Broad-spectrum antibiotics use was associated with candidiasis for individual infants. Center candidiasis incidence ranged from 2.4% to 20.4%. Center incidence of candidiasis was correlated with average broad-spectrum antibiotics use per infant and average use of broad-spectrum antibiotics with negative cultures per infant.
Center incidences of invasive candidiasis differ substantially, and antibiotic practice differences are possible contributors to center variation in candidiasis risk.</abstract><cop>Elk Grove Village, IL</cop><pub>Am Acad Pediatrics</pub><pmid>16882828</pmid><doi>10.1542/peds.2005-2677</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0031-4005 |
| ispartof | Pediatrics (Evanston), 2006-08, Vol.118 (2), p.717-722 |
| issn | 0031-4005 1098-4275 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68703643 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Antibiotics Bacterial diseases Bacterial sepsis Biological and medical sciences Birth weight Blood - microbiology Blood diseases Body fluids Candidiasis Candidiasis - epidemiology Candidiasis - etiology Carbapenems - therapeutic use Catheterization, Central Venous Central Nervous System Fungal Infections - epidemiology Central Nervous System Fungal Infections - etiology Central Nervous System Fungal Infections - microbiology Cephaloridine Cephalosporins Cephalosporins - classification Cephalosporins - therapeutic use Cerebrospinal Fluid - microbiology Comorbidity Complications and side effects Cross Infection - epidemiology Cross Infection - etiology Development and progression Diseases of mother, fetus and pregnancy Enterocolitis, Necrotizing - epidemiology Fungemia - epidemiology Fungemia - etiology Fungemia - microbiology General aspects Gram-Negative Bacterial Infections - drug therapy Gram-Negative Bacterial Infections - epidemiology Gynecology. Andrology. Obstetrics Health aspects Human bacterial diseases Humans Infant, Newborn Infant, Premature Infant, Premature, Diseases - epidemiology Infant, Premature, Diseases - etiology Infant, Very Low Birth Weight Infants (Premature) Infectious diseases Medical sciences Medical treatment Mortality Moxalactam Pediatrics Pregnancy. Fetus. Placenta Premature infants Prospective Studies Registries Risk Factors Studies Superinfection - epidemiology Superinfection - etiology |
| title | The Association of Third-Generation Cephalosporin Use and Invasive Candidiasis in Extremely Low Birth-Weight Infants |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A42%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Association%20of%20Third-Generation%20Cephalosporin%20Use%20and%20Invasive%20Candidiasis%20in%20Extremely%20Low%20Birth-Weight%20Infants&rft.jtitle=Pediatrics%20(Evanston)&rft.au=Cotten,%20C.%20Michael&rft.aucorp=National%20Institute%20for%20Child%20Health%20and%20Human%20Development%20Neonatal%20Research%20Network&rft.date=2006-08-01&rft.volume=118&rft.issue=2&rft.spage=717&rft.epage=722&rft.pages=717-722&rft.issn=0031-4005&rft.eissn=1098-4275&rft.coden=PEDIAU&rft_id=info:doi/10.1542/peds.2005-2677&rft_dat=%3Cgale_proqu%3EA156549594%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=228366417&rft_id=info:pmid/16882828&rft_galeid=A156549594&rfr_iscdi=true |